Wang Feng-Ming, chief executive and director of Ambarella, sold 6,086 ordinary shares in the company on September 17, 2026. The shares were sold at $64.83 apiece, for a total of approximately $394,555.
The transaction was intended to cover tax obligations arising from the vesting of restricted stock units. After the sale, Wang beneficially owned 767,759 Ambarella shares. That figure includes 238 shares acquired on September 15 through the company’s employee stock purchase plan.
Ambarella shares were trading at $63.12 in the information provided, after declining by roughly 26% over the previous year. An InvestingPro analysis described the stock as undervalued at current levels and included it on the platform’s Most Undervalued list.
The share sale follows Ambarella’s second-quarter fiscal 2027 results, which included revenue of $108.1 million and non-GAAP earnings of $0.18 per share. Both figures slightly exceeded Wall Street expectations of $107.76 million in revenue and $0.17 in earnings per share.
The company nevertheless pointed to margin pressure and uncertainty over memory supplies. During the quarter, Ambarella also announced agreements with Capgemini and Macnica.
Among recent analyst updates, Rosenblatt reiterated a Buy rating and set a $120 price target after the launch of Ambarella’s X7 standalone AI accelerator. Oppenheimer maintained a Perform rating, while Stifel lowered its price target to $90 from $106, citing valuation compression in the semiconductor industry, but kept a Buy rating.
Sources: Investing.com News.